DD is applying its decades of expertise in material science to meet the growing needs of the rapidly expanding IC substrate and high-end PCB market.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April 30, 2025. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of th.

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) will host a live strategy update webcast for analysts and investors on Wednesday, April 2, 2025 at 8:00 a.m. Eastern. The event will feature presentations by Fluor's Chief Executive Officer David Constable, Chief Operating Officer Jim Breuer, Chief Financial Officer John Regan and segment leaders, to discuss the company's strategic plan followed by a live question and answer session. The live webcast can be accessed, along with suppo.

This year's market correction sent many stocks sliding, creating opportunities to pick up shares of some good companies at a discount. Sirius XM Holdings (SIRI 1.17%) is one such business, but its stock was struggling well before this latest period of market volatility.

SoundHound AI (SOUN -1.26%) has been an incredibly popular AI investment pick over the past year. It first gained fame when it was revealed that AI giant Nvidia purchased a stake.

CleanSpark is in a bearish downtrend but trading in a proven demand zone, offering a good risk-to-reward opportunity. Momentum is currently bearish but showing signs of potential bullish reversal; volume suggests institutional accumulation. Relative strength is flat; CLSK has underperformed the S&P 500 since March 2024 but could outperform if it exits the demand zone.

Theresa Payton, Fortalice Solutions CEO and former White House chief information officer, joins 'Squawk Box' to discuss the fallout from 23andMe's bankruptcy filing, why users should delete their data from the website, the Trump administration's use of Signal to discuss military plans, and more.

Karen Short, Head of Consumer Research at Melius, discusses Dollar Tree's sale of Family Dollar, its impact on earnings, and consumer trends. She highlights tariff risks and potential stock upside.

It's usually a bad idea to invest in booming, hype-based stocks because they will probably fall back down to earth unless their rally is based on sustainable fundamentals. With shares down by 41% since the start of 2025, Rigetti Computing (RGTI 0.36%) is an excellent example of this phenomenon.

BD's recall of Alaris infusion pumps following software issues has been classified as the most severe recall by the FDA. A suspension of sales may hurt the top line going forward.

Many exchange-traded funds (ETFs) offer competitive annual fees—the influx of hundreds of new products to the space in recent years has driven expense ratios for many types of funds downward in a bid to attract investors.

NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against enCore Energy Corp. ("enCore" or "the Company") (NASDAQ:EU) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired enCore securities between March 28, 2024 and March 2, 2025, both dates inclusive (the "Class Period").

HOLON, Israel , March 26, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that management will participate in the following upcoming virtual investor conferences in April 2025: H.C.

MALVERN, Pa. , March 26, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT), a leading integrated and innovative global provider of advanced materials, specialty catalysts, virgin sulfuric acid and sulfuric acid regeneration services ("Ecovyst"), and Enzyme Supplies Ltd, a leading supplier of enzyme based products ("Enzyme Supplies") are pleased to announce the signing of a Memorandum of Understanding (MOU) focused on accelerating the growth of enzyme immobilization technologies.

MINNEAPOLIS , March 26, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will open a new Customer Experience Centre in Düsseldorf, Germany to serve customers across the Europe, Middle East and Africa (EMEA) region and support the company's long-term regional growth strategy. The new Customer Experience Centre is scheduled to open in summer 2026 and will feature a state-of-the-art Demonstration Laboratory hosting Bio-Techne's full instrument portfolio, including: The recently launched Leo™ System, powered by Simple Western™ Technology, which offers the throughput and precision of standard ELISAs in a fully automated western blot assay, expanding applications in bioanalytical workflows …

SCHAFFHAUSEN, Switzerland , March 26, 2025 /PRNewswire/ -- Garmin Ltd. (NYSE: GRMN) invites shareholders and investors to listen to its first quarter 2025 earnings conference call on Wednesday, April 30, 2025, at 10:30 a.m.

Lightspeed projects for the next three years: Gross profit CAGR of ~20-25%1 and Customer Location2 CAGR of ~10-15% 1 in its two growth engines - retail in North America and hospitality in Europe Consolidated gross profit CAGR of ~15-18%1 Adjusted EBITDA to grow to ~20% of gross profit in Fiscal 20281,5 Free Cash Flow5 of ~$100 million in Fiscal 20281 Lightspeed also completed Fiscal 2025 share repurchases of over $130 million 3 Additional share repurchase of up to ~$300 million authorized for a total of $430 million Lightspeed reports in US dollars and in accordance with IFRS. MONTREAL , March …

Updated data confirms statistically significant 32% higher ORR and 3.5 month longer PFS in second-line CRC patients with high DKK1 levels treated with sirexatamab plus bevacizumab and chemotherapy Statistically significant 22% higher ORR and 2.6 month longer PFS in patients who had not had prior anti-VEGF therapy Leap to host a conference call to present clinical data today, March 26, 2025, at 8:00 a.m. ET CAMBRIDGE, Mass.

LONDON--(BUSINESS WIRE)--BWT Alpine Formula One Team and luxury skiwear and lifestyle brand Perfect Moment Ltd. [NYSE American: PMNT] will come together to reveal a special-edition, capsule collection that effortlessly fuses Perfect Moment's refined ski lifestyle with the team's cutting-edge, racing performance. The sophisticated collection brings together two brands born in the French Alps with BWT Alpine Formula One Team's motor racing heritage and Perfect Moment, founded in the mountains nea.

NEW YORK, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Zynex, Inc. ("Zynex" or "the Company") (NASDAQ:ZYXI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Zynex securities between March 13, 2023 and March 11, 2025, both dates inclusive (the "Class Period").